Artigo Acesso aberto Revisado por pares

Transthyretin familial amyloid polyneuropathy impact on health-related quality of life

2015; BioMed Central; Volume: 10; Issue: Suppl 1 Linguagem: Inglês

10.1186/1750-1172-10-s1-o28

ISSN

1750-1172

Autores

Mónica Inés, Teresa Coelho, Isabel Conceição, Lara Noronha Ferreira, Mamede de Carvalho, João Costa,

Tópico(s)

Cellular transport and secretion

Resumo

Background Transthyretin Familial Amyloid Polyneuropathy (TTRFAP) is a rare, progressive, debilitating and life-threatening neurodegenerative disease. The purpose of this study was to assess the health-related quality of life (HRQoL) impairment of TTR-FAP disease versus Portuguese general population and to identify individual patient characteristics such as disease stage – that affects their HRQoL. Literature on TTR-FAP patients HRQoL is scarce at worldwide level and no evidence for Portugal has been published.

Referência(s)